|
Apr 10
|
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
|
|
Sep 27
|
Pliant Therapeutics, Inc. (PLRX) Soars 14.3%: Is Further Upside Left in the Stock?
|
|
Aug 12
|
Downgrade: Here's How Analysts See Ikena Oncology, Inc. (NASDAQ:IKNA) Performing In The Near Term
|
|
Aug 10
|
Ikena Oncology, Inc. (IKNA) Reports Q2 Loss, Lags Revenue Estimates
|
|
Aug 10
|
Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update
|
|
Aug 10
|
The Petri Dish: Agios licenses Alnylam drug, Ikena acquires startup with Gilead stake
|
|
Aug 8
|
Loss-making Ikena Oncology (NASDAQ:IKNA) sheds a further US$11m, taking total shareholder losses to 22% over 1 year
|